A B S T R A C T The intestinal absorption of [3H ]-pteroylmonoglutamate (simple folic acid) and pteroyl-,u[14C]glutamyl-y-hexaglutamate ([14C]PG-7, conjugated folic acid) was assessed by the method ofjejunal perfusion in five patients with proven celiac sprue who were studied after a gluten-containing or a gluten-free diet, and in nine normal subjects. The luminal disappearance of each folate was markedly impaired after exposure of the patients to dietary gluten and improved by gluten restriction, but not to within the range found in the normal subjects. In each experiment, column chromatography ofthe luminal aspirates revealed similar spectra ofhydrolytic products of [ sults of in vivo hydrolysis suggests that measurement of the enzyme in whole mucosal homogenates overestimates its significant digestive activity. The present studies indicate that (a) the mucosal lesion of celiac sprue significantly limits the intestinal absorption of both simple and conjugated folate, and (b) malabsorption of conjugated folate results from a combination of impaired hydrolysis and decreased mucosal uptake of hydrolytic product.
,u[14C]glutamyl-y-hexaglutamate ( [14C]PG-7, conjugated folic acid) was assessed by the method ofjejunal perfusion in five patients with proven celiac sprue who were studied after a gluten-containing or a gluten-free diet, and in nine normal subjects. The luminal disappearance of each folate was markedly impaired after exposure of the patients to dietary gluten and improved by gluten restriction, but not to within the range found in the normal subjects. In each experiment, column chromatography ofthe luminal aspirates revealed similar spectra ofhydrolytic products of [ [ "4C]PG-1 was found impaired in both celiac sprue groups, with significant improvement on treatment. In mucosal biopsies from the sprue patients, the in vitro activity of folate conjugase in whole homogenates was higher and the activity of disaccharidase lower than in a group of 12 normal mucosal biopsies. These in vitro data suggest that the predominant cellular location of mucosal folate conjugase is different from that of disaccharidase, whereas comparison with the re-
INTRODUCTION
Naturally occurring folate exists primarily as pteroylmonoglutamate, or simple folate, conjugated in ypeptide linkage with up to six additional glutamyl units (1) . Studies using synthetic folates have shown that pteroylpolyglutamates are hydrolyzed to pteroylmonoglutamate during the process of intestinal absorption (2) (3) (4) . The small intestinal mucosa is a potent source of the hydrolytic enzyme (5, 6), a y-carboxypeptidase (7) referred to as folate conjugase. Thus, intestinal malabsorption of conjugated folate could result from decreased hydrolysis, decreased intestinal absorption of the hydrolytic product pteroylmonoglutamate, or a combination of these effects. These possibilities were studied by the jejunal perfusion method in five patients with proven celiac sprue and in nine healthy control subjects. The data were supplemented by direct measurements of jejunal mucosal folate conjugase, lactase, and sucrase in saline homogenates of biopsies from the patients and from a group of 12 normal biopsies.
kins Hospital, Baltimore, Md.,' and the remaining four patients were studied at the University of California, Davis, and the Sacramento Medical Center, Sacramento, Calif. In each patient, the diagnosis of celiac sprue was indicated by the demonstration of intestinal malabsorption with a characteristic flat jejunal mucosal biopsy, features which improved with dietary gluten restriction, or which were made worse by gluten challenge. Diagnostic evaluation after each dietary regimen included measurement of levels of serum folate (8) , the daily excretion of lipid in feces collected over a 3-day period (9) , and the excretion of D-xylose in the urine collected for 5 h after a 25-g oral dose (10) . Jejunal mucosal specimens were obtained with the Crosby capsule and graded for severity according to standard criteria, with 4+ abnormality denoting a flat mucosa (11) . A portion of each specimen was frozen in a dry ice-acetone bath for subsequent enzymatic analysis. Evaluation of intestinal absorption, intestinal biopsies, and jejunal folate perfusion studies were performed twice in each patient. Four patients were studied after initial evaluation while on a gluten-containing diet, and again in clinical and laboratory remission after a 6-wk period of gluten restriction. One patient was studied first in clinical remission and again after a 10-day dietary challenge of gluten (at least four slices of whole wheat bread per day). During the treatment periods, one patient received 20 mg/day prednisone and two patients received 1 mg/day oral folic acid (Table I) . In addition, each patient received 15 mg intramuscular folic acid on completion of each perfusion to minimize isotope retention. A control group of nine healthy adults was composed of five previously reported subjects (4) and four additional healthy volunteers; eight were male and one was female, ranging in age from 25 
Jejunal perfusion studies
The jejunal perfusion solution and procedure were identical to those used in a previous study of normal subjects (4) . The materials included 3',5',9' [3H]pteroylmonoglutamate (Amersham/Searle Corp., Arlington Heights, Ill.) and pteroyl-,u['4C]glutamyl-y-hexaglutamate.2 The latter compound was synthesized by the solid-phase method so that the 14C label was on the first glutamyl unit (12) , and was provided by The Nutrition Program, University of Alabama. As described (4), these folates were purified on DEAEcellulose columns and were quantitated spectrophotometrically using peak absorbance at 256, 285, and 365 nm. The infusion solution was 1,000 ml isotonic saline, adjusted to pH 7.0 before use, containing the nonabsorbable marker polyethylene glycol, 8 
The solution was infused at 10 ml/min at a site 10 cm distal to the ligament of Treitz and, after a 50-min equilibration period, samples were collected and pooled from ports 15 and 30 cm downstream at rates of 1 ml/min. Aliquots of each aspirate pool were removed for measurements of polyethylene glycol (13) and for radioisotope counting on a Beckman-LS230 liquid scintillation counter (Beckman Instruments, Fullerton, Calif.) set for double-label counting, using a commercial scintillant (Scintisol, Isolab, Inc., Akron, Ohio). The remainder of each aspirate pool was acidified to pH 2.8 with 10%o trichloroacetic acid to inactivate enzymes and was stored at -70°C. The pools were subsequently thawed, neutralized, and subjected to column chromatography to detect oxidized products of hydrolysis of ['4C]PG-7. These procedures do not alter the specific activities of the folates employed in these studies (4) . The chromatographic procedures, employing DEAEcellulose, a linear sodium chloride gradient, and spectrally pure nonradioactive pteroylglutamate markers, were exactly as described previously (4) . These methods have proven effective in separating oxidized pteroylglutamates (14) , which are spectrally distinct from reduced and substituted folates (15) . These chromatographic techniques permitted greater than 90% recovery of ['4C]pteroylglutamates, which were entirely in the oxidized spectrum.
In vitro studies
To determine the possible presence of unbound folate conjugase within the luminal contents, ["4C]PG-7 was exposed in vitro to intestinal juice under physical conditions similar to those employed in the perfusion studies. The initial perfusion of patient D. R. was preceded by a 60-min perfusion with isotonic saline. 25 ml of the pooled aspirates from the saline perfusion was incubated with ['4C]PG-7 in a 2-,uM concentration for 15 min at 37°C at (intraluminal) pH 5.0, after which 10%o trichloroacetic acid was added to bring the pH to 2.8, and the reactant mixture was then subjected to column chromatography to detect reactant products.
Jejunal mucosa obtained by biopsy from patient D. R. before treatment was homogenized in 2 ml of cold saline using a glass homogenizer. 1 in a 2.0-ml volume for 15 min at 37°C. The reaction was stopped by the addition of 0.5 ml of 100% trichloroacetic acid and, after centrifugation, the supemate was subjected to the column-chromatographic procedure described above. A similar procedure was followed using a whole saline homogenate of normal jejunal mucosa which contained 2.38 mg protein/ml. Jejunal perfusion studies. Net secretion of water into the perfused lumen was observed in 9 of the 10 studies of the sprue patients (Table II) . The rate of net water secretion was not significantly different in studies performed after dietary gluten (G) or in clinical remission (gluten-free diet, GF) and contrasted with net water absorption in the control group (P < 0.001). (Fig. 2) . After incubation of [14C]PG-7 with a whole saline homogenate of jejunal mucosa obtained from patient D. R. and from a normal subject, column chromatography revealed seven peaks of "4C-labeled pteroylglutamates (Fig. 3) (Fig. 4) . In 12 normal biopsies, the activity of folate conjugase ranged from 2.6 to 6.5 nmol/mg protein per 15 min with a mean of 4.2 +0.31, significantly less than either sprue group. However, the activities of lactase and sucrase were significantly greater in the control group than in the sprue patients (Fig. 4) .
DISCUSSION
Folate deficiency is a frequent cause of anemia in untreated celiac sprue (21) . Previous studies in celiac sprue using oral doses of folate and measurements of serum levels and urinary excretion described folic 936
C. markedly decreased in celiac sprue. As indicated by changes after treatment or gluten challenge, the impairment of luminal folate disappearance was related to the functional and histological severity of the mucosal lesion (Tables I and II) . The data also suggest that patients with celiac sprue in early clinical remission are at continued risk for folate malabsorption and deficiency. The finding of net water secretion into the jejunum is consistent with observations of others who perfused the small intestine in untreated (25, 26) and in treated celiac sprue (26 (Fig. 1). (b (Fig. 2) . These data, supported by the findings presented in Fig. 3 
